CR11442A - Producto de dispersion solida de drogas basadas en n-aril urea - Google Patents

Producto de dispersion solida de drogas basadas en n-aril urea

Info

Publication number
CR11442A
CR11442A CR11442A CR11442A CR11442A CR 11442 A CR11442 A CR 11442A CR 11442 A CR11442 A CR 11442A CR 11442 A CR11442 A CR 11442A CR 11442 A CR11442 A CR 11442A
Authority
CR
Costa Rica
Prior art keywords
solid dispersion
urea
aril
dispersion product
drugs based
Prior art date
Application number
CR11442A
Other languages
English (en)
Spanish (es)
Inventor
Schroeder Rudolf
Heitermann Tanja
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of CR11442A publication Critical patent/CR11442A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CR11442A 2007-10-19 2010-05-19 Producto de dispersion solida de drogas basadas en n-aril urea CR11442A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99961807P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
CR11442A true CR11442A (es) 2010-09-06

Family

ID=40089463

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11442A CR11442A (es) 2007-10-19 2010-05-19 Producto de dispersion solida de drogas basadas en n-aril urea

Country Status (18)

Country Link
EP (1) EP2197425A2 (pt)
JP (1) JP2011500649A (pt)
KR (1) KR20100087170A (pt)
CN (1) CN101827584A (pt)
AU (1) AU2008313622A1 (pt)
BR (1) BRPI0818340A2 (pt)
CA (1) CA2699301A1 (pt)
CO (1) CO6270206A2 (pt)
CR (1) CR11442A (pt)
DO (1) DOP2010000117A (pt)
EC (1) ECSP10010183A (pt)
GT (1) GT201000102A (pt)
MX (1) MX2010004291A (pt)
PA (1) PA8800101A1 (pt)
RU (1) RU2010119929A (pt)
UA (1) UA100865C2 (pt)
WO (1) WO2009050291A2 (pt)
ZA (1) ZA201002095B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009100176A2 (en) * 2008-02-07 2009-08-13 Abbott Laboratories Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
AR077975A1 (es) 2009-08-28 2011-10-05 Irm Llc Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
BR112012031516A2 (pt) * 2010-06-09 2016-11-08 Abbott Lab dispersões sólidas contendo inibidores de quinase
RU2622015C2 (ru) 2011-11-11 2017-06-08 Новартис Аг Способ лечения пролиферативного заболевания
SI2782557T1 (sl) * 2011-11-23 2019-02-28 Array Biopharma, Inc., Farmacevtske formulacije
WO2014003677A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
ES3063790T3 (en) 2015-06-09 2026-04-20 Lonza Sales Ag Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1959926A1 (en) * 2005-10-25 2008-08-27 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
WO2007066189A2 (en) * 2005-12-09 2007-06-14 Pfizer Products Inc. Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
EP2089003A1 (en) * 2006-11-09 2009-08-19 Abbott GmbH & Co. KG Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor

Also Published As

Publication number Publication date
CN101827584A (zh) 2010-09-08
WO2009050291A3 (en) 2010-04-08
AU2008313622A1 (en) 2009-04-23
UA100865C2 (ru) 2013-02-11
CA2699301A1 (en) 2009-04-23
EP2197425A2 (en) 2010-06-23
JP2011500649A (ja) 2011-01-06
BRPI0818340A2 (pt) 2015-04-22
CO6270206A2 (es) 2011-04-20
KR20100087170A (ko) 2010-08-03
WO2009050291A2 (en) 2009-04-23
PA8800101A1 (es) 2009-05-15
ECSP10010183A (es) 2010-06-29
RU2010119929A (ru) 2011-11-27
GT201000102A (es) 2012-03-12
DOP2010000117A (es) 2010-05-15
MX2010004291A (es) 2010-08-02
ZA201002095B (en) 2011-11-30

Similar Documents

Publication Publication Date Title
DOP2010000114A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea
CR11442A (es) Producto de dispersion solida de drogas basadas en n-aril urea
AR080736A1 (es) Composicion farmaceutica de disolucion rapida, usualmente bucodispersable, y proceso para prepararla
CR9292A (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
UY30139A1 (es) Formulacion farmaceuica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
AR062059A1 (es) Espuma farmaceutica con acido graso
CL2015001961A1 (es) (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
CO6251200A2 (es) Metodo para modular la tasa de liberacion de ingredientes activos microencapsulados usado paa la proteccion de cultivos
AR086115A1 (es) Formulaciones parenterales mejoradas de agentes farmaceuticos lipofilos y los metodos para la preparacion y el uso de las mismas
NZ602442A (en) A fast dissolving pharmaceutical composition
CO7131367A2 (es) Formulación compuesta que comprende una tableta esferoidal de múltiples unidades (must) en cápsulada en cápsula dura y método para su preparación
CL2013003161A1 (es) Composicion farmaceutica en forma de microgranulos de disolucion rapida para administracion vaginal que comprende a) un farmaco vaginalmente activo, b) un excipiente polimerico, c) un alcohol de azucar, sacarido o una mezcla de los mismos; procedimiento de preparacion.
CL2013000488A1 (es) Co-cristales de compuestos derivados de (2r)-5-oxo-1-(bencilpiperidin-4-il)-n-(piridin-2-il)pirrolidin-2-carboxamida y un agente de formacion de co-cristales; sales de los compuestos; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias e infecciosas.
PE20091949A1 (es) Formulacion farmaceutica solida con liberacion retardada
ECSP15022442A (es) Producto de comicronización que comprende acetato de ulipristal
ECSP15022501A (es) Dispersión sólida de un modulador selectivo de los receptores de progesterona
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
CL2011001207A1 (es) Extruidos que contienen al menos una sustancia farmacéuticamente activa en forma de agujas, tal que la relación entre el tamaño de partículas de la sustancia farmacéuticamente activa con forma de agujas y el diámetro de la cadena es de al menos 1:20; composición farmacéutica; y su uso para preparar medicamentos.
AR086491A1 (es) Composicion farmaceutica que comprende fexofenadina
AR062626A1 (es) Comprimidos de polimero de poliestireno sulfonato, su preparacion y uso
CO6270249A2 (es) Fibra, pelicula o espuma que comprende un plastificador y un gel ligado a arcilla cargado y metodos para su produccion
AR093922A1 (es) Composicion farmaceutica que contiene telmisartan
AR105503A1 (es) Concentrado que contiene alprostadil
CO2017011220A2 (es) Proceso para la fabricación de mezclas de polvo seco

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)